A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104723 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jiao Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Drug Resistance, Neoplasm, Nanoparticles. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Temozolomide (TMZ) remains the frontline chemotherapy for gliomas; yet its clinical efficacy is significantly compromised by inherent instability and the emergence of resistance mechanisms. To surmount these challenges, we engineered a squalenoylated TMZ nanoparticle (SQ-TMZ NPs) via conjugation of TMZ with squalene, enabling enhanced drug stability and improved therapeutic potency against glioblastoma cells. The resulting SQ-TMZ NPs exhibited a precisely controlled nanoscale architecture (~126 nm), demonstrating exceptional stability under physiological and storage conditions, with minimal hemolytic toxicity (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.
- Shuren College, Zhejiang Chinese Medical University, Hangzhou 310053, China.
ORCID-Profile: Jiao Feng, Chengyong Wen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Feng, J., Wen, C., Zhang, X., Zhu, X., Ma, M., Zhao, X., & Sui, X. (2025). A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104723
Vancouver
Feng J, Wen C, Zhang X, Zhu X, Ma M, Zhao X, et al. A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104723
BibTeX
@article{Feng2025,
author = {Feng, Jiao and Wen, Chengyong and Zhang, Xiao and Zhu, Xiaolong and Ma, Mengmeng and Zhao, Xiaohong and Sui, Xinbing},
title = {A Novel Squalenoylated Temozolomide Nanoparticle with Long Circulating Properties Reverses Drug Resistance in Glioblastoma},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104723}
}
EUVIMED